Compound Detail
CHEMBL2368925
DOLASETRON 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12
Basic Information
| ChEMBL ID | CHEMBL2368925 |
| Name | DOLASETRON |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | UKTAZPQNNNJVKR-KJGYPYNMSA-N |
| Therapeutic | ✓ Yes |
1
Targets
6
Activities
1
Assay Types
4
PK Parameters
20
Publications
1
Known Names
3
Indications
Molecular Properties
324.4
MW (Da)
2.52
ALogP
4
HBA
1
HBD
62.4
PSA (Ų)
0.86
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1997 |
| Availability | Discontinued |
| Chirality | Single Enantiomer |
Indications
Nausea Nausea Fibromyalgia
ATC Classification
A04AA04
dolasetron
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: ANTIEMETICS AND ANTINAUSEANTS
Activity Summary
IC50 6 meas. best 5.22
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.22 | 5.07 | 5950.0 | 6 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 180.0 | mL.min-1.kg-1 | Homo sapiens |
| MRT | 0.19 | hr | Homo sapiens |
| T1/2 | 0.13 | hr | Homo sapiens |
| Vd | 5.8 | L.kg-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 26948801 | 10.1016/j.drudis.2016.02.015 | Homo sapiens | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 2 |
| 21055935 | 10.1016/j.bmcl.2010.10.068 | No relevant target | 1 |
| 19110341 | 10.1016/j.ejmech.2008.11.009 | No relevant target | 1 |
| 23454828 | 10.1124/dmd.112.050278 | No relevant target | 1 |
| 19110341 | 10.1016/j.ejmech.2008.11.009 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 18448342 | 10.1016/j.bmc.2008.04.028 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| 15745831 | 10.1016/j.bmcl.2005.01.008 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 1 |
| 12873512 | 10.1016/s0960-894x(03)00492-x | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine